A Study to Investigate LYL797 in Adults With Solid Tumors

Clinical trial NCT05274451 · TERMINATED

Trial details

NCT number: NCT05274451
Sponsor: Lyell Immunopharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer TNBC - Triple-Negative Breast Cancer Non-small Cell Lung Cancer Non Small Cell Lung Cancer Non Small Cell Lung Cancer Metastatic Non-Small Cell Carcinoma of Lung, TNM Stage 4 Advanced Breast Cancer Advanced Lung Carcinoma NSCLC NSCLC, Recurrent NSCLC Stage IV Relapsed Cancer

Start date: 2022-03-29
Primary completion: 2024-11-27
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.